{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:34:57Z","timestamp":1771054497767,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.pnpbp.2007.09.014","type":"journal-article","created":{"date-parts":[[2007,10,25]],"date-time":"2007-10-25T10:07:24Z","timestamp":1193306844000},"page":"437-444","source":"Crossref","is-referenced-by-count":12,"title":["Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: A randomized, open-label, 12-week, parallel-group trial"],"prefix":"10.1016","volume":"32","author":[{"given":"Changsu","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Un","family":"Pae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bun Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Hoon","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash S.","family":"Masand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwin A.","family":"Patkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Kwa","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2007.09.014_bib1","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib2","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1176\/appi.ajp.161.9.1642","article-title":"Efficacy of sertraline in a 12-week trial for generalized anxiety disorder","volume":"161","author":"Allgulander","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejpain.2004.03.003","article-title":"Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder","volume":"9","author":"Aragona","year":"2005","journal-title":"Eur J Pain"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0002-9343(01)01089-0","article-title":"A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia","volume":"112","author":"Arnold","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1176\/appi.psy.47.6.498","article-title":"Somatoform disorder in primary care: course and the need for cognitive-behavioral treatment","volume":"47","author":"Arnold","year":"2006","journal-title":"Psychosomatics"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1023\/A:1005268425375","article-title":"The state of the serotonin transporter protein in the platelets of patients with somatoform [correction of somatiform] disorders","volume":"31","author":"Belous","year":"2001","journal-title":"Neurosci Behav Physiol"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/1363461505052660","article-title":"Shenjing shuairuo and the DSM-IV: diagnosis, distress, and disability in a Chinese primary care setting","volume":"42","author":"Chang","year":"2005","journal-title":"Transcult Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1526-4610.1999.3910716.x","article-title":"Fluoxetine for migraine prophylaxis: a double-blind trial","volume":"39","author":"d'Amato","year":"1999","journal-title":"Headache"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1600-0447.2005.00529.x","article-title":"Sertraline in generalized anxiety disorder: efficacy in treating the psychic and somatic anxiety factors","volume":"111","author":"Dahl","year":"2005","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1192\/bjp.184.6.470","article-title":"Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders","volume":"184","author":"de Waal","year":"2004","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0022-3999(98)00101-9","article-title":"Somatized mental disorder among primary care Arab patients: I. Prevalence and clinical and sociodemographic characteristics.","volume":"46","author":"El-Rufaie","year":"1999","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004850-200503000-00004","article-title":"The relationship between early changes in the HAMD-17 anxiety\/somatization factor items and treatment outcome among depressed outpatients","volume":"20","author":"Farabaugh","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00800664","article-title":"Epidemiology of somatoform disorders: a community survey in Florence","volume":"32","author":"Faravelli","year":"1997","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0165-0327(99)00131-7","article-title":"Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression","volume":"59","author":"Fava","year":"2000","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0033-3182(99)71228-4","article-title":"Somatization in primary care. Prevalence, health care utilization, and general practitioner recognition.","volume":"40","author":"Fink","year":"1999","journal-title":"Psychosomatics"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/bmj.2.5707.439","article-title":"Psychiatric illness in general practice. A detailed study using a new method of case identification","volume":"1","author":"Goldberg","year":"1970","journal-title":"Br Med J"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib18","first-page":"S5","article-title":"Selective serotonin reuptake inhibitors in affective disorders\u2014I. Basic pharmacology","volume":"12","author":"Goodnick","year":"1998","journal-title":"4"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib19","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1177\/0269881198012003031","article-title":"Selective serotonin reuptake inhibitors in affective disorders\u2014II. Efficacy and quality of life.","volume":"12","author":"Goodnick","year":"1998","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1176\/appi.psy.44.4.304","article-title":"Specific somatoform disorder in the general population","volume":"44","author":"Grabe","year":"2003","journal-title":"Psychosomatics"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1525-1497.2004.30531.x","article-title":"The outcome of physical symptoms with treatment of depression","volume":"19","author":"Greco","year":"2004","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00221-002-1352-x","article-title":"Serotonin receptors 5-HT1A and 5-HT3 reduce hyperexcitability of dorsal horn neurons after chronic spinal cord hemisection injury in rat","volume":"149","author":"Hains","year":"2003","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1176\/ajp.148.1.34","article-title":"Somatization: a spectrum of severity","volume":"148","author":"Katon","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1176\/appi.psy.44.6.471","article-title":"Somatic symptoms in primary care: etiology and outcome","volume":"44","author":"Khan","year":"2003","journal-title":"Psychosomatics"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/mpr.140","article-title":"Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management","volume":"12","author":"Kroenke","year":"2003","journal-title":"Int J Methods Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib27","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archpsyc.1997.01830160080011","article-title":"Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care","volume":"54","author":"Kroenke","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00006842-200203000-00008","article-title":"The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms","volume":"64","author":"Kroenke","year":"2002","journal-title":"Psychosom Med"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4088\/JCP.v67n0111","article-title":"Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder","volume":"67","author":"Kroenke","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/sti.2004.010868","article-title":"The response to sertraline in men with chronic pelvic pain syndrome","volume":"81","author":"Lee","year":"2005","journal-title":"Sex Transm Infect"},{"issue":"9","key":"10.1016\/j.pnpbp.2007.09.014_bib30","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s00127-007-0218-8","article-title":"Current somatoform disorders in Norway: prevalence, risk factors and comorbidity with anxiety, depression and musculoskeletal disorders","volume":"42","author":"Leiknes","year":"2007","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"Suppl 2","key":"10.1016\/j.pnpbp.2007.09.014_bib31","first-page":"S1","article-title":"The epidemiology of comorbidity between depression, anxiety disorders and somatic diseases","volume":"14","author":"Maier","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-1999-7958","article-title":"Gabapentin leads to remission of somatoform pain disorder with major depression","volume":"32","author":"Maurer","year":"1999","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib33","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.psy.0000128900.13711.5b","article-title":"Treatment of somatoform disorders with St John's wort: a randomized, double-blind and placebo-controlled trial","volume":"66","author":"Muller","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib35","first-page":"980","article-title":"Antidepressant therapy for unexplained symptoms and symptom syndromes","volume":"48","author":"O'Malley","year":"1999","journal-title":"J Fam Pract"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib34","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1525-1497.2000.06279.x","article-title":"Treatment of fibromyalgia with antidepressants: a meta-analysis","volume":"15","author":"O'Malley","year":"2000","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(92)90144-Z","article-title":"Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies","volume":"49","author":"Onghena","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0404.1990.tb01584.x","article-title":"A randomized, within-patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain","volume":"82","author":"Panerai","year":"1990","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib38","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.amjmed.2006.06.006","article-title":"A randomized, controlled, trial of controlled release paroxetine in fibromyalgia","volume":"120","author":"Patkar","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib39","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1213\/00000539-199608000-00029","article-title":"An evaluation of antidepressants in rheumatic pain conditions","volume":"83","author":"Rani","year":"1996","journal-title":"Anesth Analg"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/1520-6394(2001)13:1<18::AID-DA3>3.0.CO;2-M","article-title":"Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression","volume":"13","author":"Russell","year":"2001","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib41","first-page":"CD005454","article-title":"Antidepressants for neuropathic pain","author":"Saarto","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1006986824213","article-title":"Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding","volume":"19","author":"Sanchez","year":"1999","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1526-4610.1994.hed3409497.x","article-title":"Double-blind trial of fluoxetine: chronic daily headache and migraine","volume":"34","author":"Saper","year":"1994","journal-title":"Headache"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0304-3940(98)00937-9","article-title":"Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients","volume":"259","author":"Schwarz","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib45","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1016\/j.febslet.2006.11.012","article-title":"Descending serotonergic facilitation of spinal ERK activation and pain behavior","volume":"580","author":"Svensson","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib46","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0002-9343(01)00762-8","article-title":"Treatment of chronic headache with antidepressants: a meta-analysis","volume":"111","author":"Tomkins","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib47","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4088\/JCP.v63n0905","article-title":"A randomized controlled trial of fluvoxamine in prostatodynia, a male somatoform pain disorder","volume":"63","author":"Turkington","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib48","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2036.2005.02566.x","article-title":"The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study","volume":"22","author":"Vahedi","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib49","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/0006-3223(92)90276-6","article-title":"Biochemical measures in patients with a somatoform pain disorder, before, during, and after treatment with amitriptyline with or without flupentixol","volume":"31","author":"Van Kempen","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib50","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1067\/mhj.2000.108514","article-title":"Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin","volume":"140","author":"Varia","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0924-977X(00)00074-2","article-title":"Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial","volume":"10","author":"Volz","year":"2000","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib52","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00213-002-1171-6","article-title":"St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial","volume":"164","author":"Volz","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2007.09.014_bib53","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.1523\/JNEUROSCI.1623-07.2007","article-title":"Mice lacking central serotonergic neurons show enhanced inflammatory pain and an impaired analgesic response to antidepressant drugs","volume":"27","author":"Zhao","year":"2007","journal-title":"J Neurosci"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584607003430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584607003430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T11:23:49Z","timestamp":1546514629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584607003430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0278584607003430"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2007.09.014","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}